Liminatus Pharma Secures $650,002 in Private Placement Funding
PUBLIC · LIMNNov 03, 2026
Amount Raised
$650,000
Round Type
Post-IPO Equity
La PalmaBiotechnologyPharmaceutical
Investors
Non-U.S. Investor
Description
On November 2, 2026, Liminatus Pharma, Inc. entered into a subscription agreement with a non-U.S. investor for the issuance of 260,001 shares of common stock. The private placement is expected to close on or about November 20, 2026
Who to call at Liminatus Pharma, and when
A new round usually means Liminatus Pharma is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Liminatus Pharma raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Liminatus Pharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Liminatus Pharma. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Liminatus Pharma
Location
La Palma, California, United States
About
Liminatus Pharma, LLC is a private pharmaceutical company that is set to be integrated into Iris Acquisition Corp through a proposed business combination. The merger aims to bring Liminatus into the public market by becoming a part of Iris's corporate structure.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Liminatus Pharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
La PalmaBiotechnologyPharmaceutical